Literature DB >> 26629084

Commonly administered bacille Calmette-Guerin strains induce comparable immune response.

Jun-Fang Wang1, Fu-Ying Dai1, Xue-Li Gong1, Lang Bao1.   

Abstract

Bacille Calmette-Guerin (BCG) is currently the only available vaccine against tuberculosis (TB), but its protective efficacy in adults is highly variable. This study aimed to compare the immune response induced by two widely used BCG strains: BCG China strain (derivative of BCG Danish strain) in DU2-III group and BCG Pasteur in DU2 -IV group. Healthy BALB/c mice were immunized with BCG China strain or BCG Pasteur strain. Specific IgG, IgG1, and IgG2a antibodies titers, the proliferation of splenocytes, the percentages of splenocyte subsets and the concentrations of induced IFN-γ and IL-4 at 6(th), 8(th), 10(th), and 12(th) weeks after the immunization were detected. We found that BCG Pasteur strain induced higher specific IgG and IgG1 titers, higher proliferation of splenocytes, higher percentages of CD4(+) or CD8(+) T cells, and higher concentration of secreted IFN-γ than BCG China strain. However, there were no significant differences in IgG2a titer and IL-4 concentration between both strains. In conclusion, our study shows that immune responses to BCG vaccine differ by strain, which may account for variable outcomes of BCG immunization.

Entities:  

Keywords:  BCG China; BCG Pasteur; immunogenicity

Year:  2015        PMID: 26629084      PMCID: PMC4658973     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

Review 1.  The success and failure of BCG - implications for a novel tuberculosis vaccine.

Authors:  Peter Andersen; T Mark Doherty
Journal:  Nat Rev Microbiol       Date:  2005-08       Impact factor: 60.633

2.  The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants.

Authors:  Virginia Davids; Willem A Hanekom; Nazma Mansoor; Hoyam Gamieldien; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; E Jane Hughes; Jorge Soler; Rose Ann Murray; Stanley R Ress; Gilla Kaplan
Journal:  J Infect Dis       Date:  2006-01-13       Impact factor: 5.226

3.  Sex differences in the vaccine-specific and non-targeted effects of vaccines.

Authors:  Katie L Flanagan; Sabra L Klein; Niels E Skakkebaek; Ian Marriott; Arnaud Marchant; Liisa Selin; Eleanor N Fish; Andrew M Prentice; Hilton Whittle; Christine Stabell Benn; Peter Aaby
Journal:  Vaccine       Date:  2011-02-05       Impact factor: 3.641

4.  A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity.

Authors:  Xiaoling Yang; Lang Bao; Yihao Deng
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-06-14       Impact factor: 3.848

5.  Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis.

Authors:  Helmy Rachman; Michael Strong; Timo Ulrichs; Leander Grode; Johannes Schuchhardt; Hans Mollenkopf; George A Kosmiadi; David Eisenberg; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 6.  Immune markers and correlates of protection for vaccine induced immune responses.

Authors:  Aneesh Thakur; Lasse E Pedersen; Gregers Jungersen
Journal:  Vaccine       Date:  2012-05-30       Impact factor: 3.641

7.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

Review 8.  IL-4 in tuberculosis: implications for vaccine design.

Authors:  Graham A W Rook; Rogelio Hernandez-Pando; Keertan Dheda; Geok Teng Seah
Journal:  Trends Immunol       Date:  2004-09       Impact factor: 16.687

Review 9.  Influence of BCG vaccine strain on the immune response and protection against tuberculosis.

Authors:  Nicole Ritz; Willem A Hanekom; Roy Robins-Browne; Warwick J Britton; Nigel Curtis
Journal:  FEMS Microbiol Rev       Date:  2008-07-09       Impact factor: 16.408

10.  Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.

Authors:  Andrea S Leung; Vanessa Tran; Zuowei Wu; Xuping Yu; David C Alexander; George Fu Gao; Baoli Zhu; Jun Liu
Journal:  BMC Genomics       Date:  2008-09-15       Impact factor: 3.969

View more
  4 in total

1.  BCG and Kawasaki disease in Mexico and Japan.

Authors:  Luisa Berenise Gamez-Gonzalez; Hiromichi Hamada; Beatriz Adriana Llamas-Guillen; Miguel Ruiz-Fernandez; Marco Yamazaki-Nakashimada
Journal:  Hum Vaccin Immunother       Date:  2017-03-10       Impact factor: 3.452

2.  Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.

Authors:  Fu-Ying Dai; Jun-Fang Wang; Xue-Li Gong; Lang Bao
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

3.  Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined Immunodeficiency.

Authors:  Anderson Dik Wai Luk; Pamela P Lee; Huawei Mao; Koon-Wing Chan; Xiang Yuan Chen; Tong-Xin Chen; Jian Xin He; Nadia Kechout; Deepti Suri; Yin Bo Tao; Yong Bin Xu; Li Ping Jiang; Woei Kang Liew; Orathai Jirapongsananuruk; Tassalapa Daengsuwan; Anju Gupta; Surjit Singh; Amit Rawat; Amir Hamzah Abdul Latiff; Anselm Chi Wai Lee; Lynette P Shek; Thi Van Anh Nguyen; Tek Jee Chin; Yin Hsiu Chien; Zarina Abdul Latiff; Thi Minh Huong Le; Nguyen Ngoc Quynh Le; Bee Wah Lee; Qiang Li; Dinesh Raj; Mohamed-Ridha Barbouche; Meow-Keong Thong; Maria Carmen D Ang; Xiao Chuan Wang; Chen Guang Xu; Hai Guo Yu; Hsin-Hui Yu; Tsz Leung Lee; Felix Yat Sun Yau; Wilfred Hing-Sang Wong; Wenwei Tu; Wangling Yang; Patrick Chun Yin Chong; Marco Hok Kung Ho; Yu Lung Lau
Journal:  Front Immunol       Date:  2017-07-12       Impact factor: 7.561

4.  Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains.

Authors:  Andreon Santos Machado da Silva; Lawrence Henrique Paz Albuquerque; Carlos Germano Garrido de Ponte; Matheus Rogério de Almeida; Sandra Elizabete Ribeiro de Faria; Mariana da Silva Ribeiro; Evelyn Nunes Goulart da Silva Pereira; Paulo Renato Zuquim Antas
Journal:  Hum Vaccin Immunother       Date:  2021-11-12       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.